Accession Number: | 0001567619-19-018220 |
Date: | 2019-09-10 |
Issuer: | STOKE THERAPEUTICS, INC. (STOK) |
Original Submission Date: |
KRAINER ADRIAN R.
C/O STOKE THERAPEUTICS, INC.
45 WIGGINS AVENUE
BEDFORD, MA 01730
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DIRECTOR STOCK OPTION (RIGHT TO BUY) | 28.8 | 2019-09-10 | deemed execution date | A | 14,777 (a) | 2029-09-09 | common stock 14,777 | $28.80 | 14,777 | direct |
ID | footnote |
---|---|
f1 | this option vests 100% and becomes exercisable on june 21, 2020, subject to reporting person's continued service through such vesting date. |